Fluoxetine (SSRI)
Treatment for Premenstrual Syndrome
Typical Dosage: 10-20mg daily
Effectiveness
80%
Safety Score
60%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
10-20mg daily
Time to Effect
1-2 weeks
Treatment Duration
Continuous or luteal phase
Evidence Quality
HIGHNumber Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
10(Treat 10 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$100
Side Effect Mgmt:$50
Total Annual:$225
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$45,000/QALY
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$321
Cost per Remission
$563
Comparison vs Placebo
Cost Difference
+$225/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Fluoxetine (SSRI) Outcomes
for Premenstrual Syndrome
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Remission Rate
+40%
Common Side Effects
Nausea
+20%
Insomnia
+15%
Sexual dysfunction
+30%
Headache
+10%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov